Position in SCLX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$257,899
+$12,388 QoQ
Shares Held
33,064
-44.2% QoQ
Ownership
0.389%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 72 holders
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $598,181,374 across 8 Drug Manufacturers - General names. SCLX ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
2,217,376 | $280,143,283 | |
| 2 | NVO |
Novo Nordisk A S
|
3,032,421 | $145,374,262 | |
| 3 | NVS |
Novartis AG
|
788,033 | $123,500,531 | |
| 4 | LLY |
ELI LILLY & Co
|
26,091 | $31,294,330 | |
| 5 | BIIB |
Biogen Inc.
|
77,744 | $16,797,368 | |
| 6 | AMRN |
Amarin Corp Plc\Uk
|
48,369 | $771,001 | |
| 7 | SCLX |
Scilex Holding Co
This page
|
33,064 | $257,899 | |
| 8 | NSRX |
Nasus Pharma Ltd
|
12,200 | $42,700 |
All Filings in SCLX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $257,899 | 33,064 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $245,511 | 36,864 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $469,259 | 38,464 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $377,146 | 19,164 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $16,558 | 66,500 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $104,851 | 51,398 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $18,929 | 13,521 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||